Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab
- PMID:15858507
- DOI: 10.1016/j.jaad.2004.09.006
Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab
Abstract
Acne fulminans is a syndrome of sudden onset hemorrhagic and ulcerative acne involving the back, chest, and face combined with systemic symptoms. It can be the dermatologic manifestation of the synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome. Current therapy for acne fulminans consists of wound care, topical and systemic corticosteroids, isotretinoin, and nonsteroidal anti-inflammatory drugs (NSAIDs). Infliximab, a recently developed monoclonal antibody against tumor necrosis factor-alfa, has shown efficacy in the treatment of psoriatic arthritis and ankylosing spondylitis both of which share clinical similarities to the SAPHO syndrome. We report the case of a patient with the SAPHO syndrome and acne fulminans who was treated with infliximab. Ten months after initiating therapy with infliximab, the area of the patient's ulcerative lesions was reduced by 70%. Infliximab might be considered as a treatment option for patients with acne fulminans unresponsive to conventional therapies.
Similar articles
- Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature.Moll C, Hernández MV, Cañete JD, Gómez-Puerta JA, Soriano A, Collado A, Sanmartí R.Moll C, et al.Semin Arthritis Rheum. 2008 Apr;37(5):299-306. doi: 10.1016/j.semarthrit.2007.08.004. Epub 2007 Oct 31.Semin Arthritis Rheum. 2008.PMID:17976692Review.
- SAPHO syndrome treated with pamidronate: an open-label study of 10 patients.Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A.Amital H, et al.Rheumatology (Oxford). 2004 May;43(5):658-61. doi: 10.1093/rheumatology/keh149. Epub 2004 Feb 24.Rheumatology (Oxford). 2004.PMID:14983108Clinical Trial.
- In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations.Massara A, Cavazzini PL, Trotta F.Massara A, et al.Rheumatology (Oxford). 2006 Jun;45(6):730-3. doi: 10.1093/rheumatology/kei221. Epub 2006 Jan 10.Rheumatology (Oxford). 2006.PMID:16403830
- Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome complicated by seven pulmonary emboli in a 15-year old patient.Coloe J, Diamantis S, Henderson F, Morrell DS.Coloe J, et al.J Am Acad Dermatol. 2010 Feb;62(2):333-6. doi: 10.1016/j.jaad.2009.02.049.J Am Acad Dermatol. 2010.PMID:20115954
- Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work.Zhao Z, Li Y, Li Y, Zhao H, Li H.Zhao Z, et al.J Dermatol. 2011 Feb;38(2):155-9. doi: 10.1111/j.1346-8138.2010.00931.x. Epub 2010 Nov 11.J Dermatol. 2011.PMID:21269311Review.
Cited by
- New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations.Cheng W, Li F, Tian J, Xie X, Chen JW, Peng XF, Tang Q, Ge Y.Cheng W, et al.J Inflamm Res. 2022 Apr 13;15:2365-2380. doi: 10.2147/JIR.S353539. eCollection 2022.J Inflamm Res. 2022.PMID:35444448Free PMC article.Review.
- Bone marker response in chronic diffuse sclerosing osteomyelitis treated with intravenous ibandronate.Armstrong DJ, Wright SA, Coward SM, Finch MB.Armstrong DJ, et al.Ann Rheum Dis. 2006 Jul;65(7):976-7. doi: 10.1136/ard.2005.047217.Ann Rheum Dis. 2006.PMID:16769790Free PMC article.No abstract available.
- SAPHO: has the time come for tailored therapy?Figueiredo ASB, Oliveira AL, Caetano A, Moraes-Fontes MF.Figueiredo ASB, et al.Clin Rheumatol. 2020 Jan;39(1):177-187. doi: 10.1007/s10067-019-04675-2. Epub 2019 Jul 16.Clin Rheumatol. 2020.PMID:31312988Review.
- Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism.Sabugo F, Liberman C, Niedmann JP, Soto L, Cuchacovich M.Sabugo F, et al.Clin Rheumatol. 2008 Apr;27(4):533-5. doi: 10.1007/s10067-007-0767-y. Epub 2007 Oct 16.Clin Rheumatol. 2008.PMID:17938987
- [Dermatological symptoms in rheumatology].Aberer E.Aberer E.Z Rheumatol. 2008 Sep;67(5):372, 374-8, 380-5. doi: 10.1007/s00393-008-0341-2.Z Rheumatol. 2008.PMID:18685856Review.German.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Research Materials